Incyte CorporationIncyte CorporationIncyte Corporation

Incyte Corporation

No trades
See on Supercharts
Market capitalization
‪12.33 B‬USD
‪597.60 M‬USD
‪3.70 B‬USD
‪221.84 M‬
Beta (1Y)
0.90

About Incyte Corporation

CEO
Herve Hoppenot
Headquarters
Wilmington
Website
Employees (FY)
‪2.52 K‬
Founded
1991
ISIN
US45337C1027
FIGI
BBG000BNPSQ9
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of INCY is 53.85 USD — it has decreased by 1.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Incyte Corporation stocks are traded under the ticker INCY.
Incyte Corporation is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Incyte Corporation has a max estimate of 92.00 USD and a min estimate of 60.00 USD.
INCY earnings for the last quarter are 1.10 USD whereas the estimation was 0.83 USD which accounts for 31.93% surprise. Estimated earnings for the next quarter are 1.15 USD. See more details about Incyte Corporation earnings.
Incyte Corporation revenue for the last quarter amounts to ‪919.03 M‬ USD despite the estimated figure of ‪963.63 M‬ USD. In the next quarter revenue is expected to reach ‪1.00 B‬ USD.
Yes, you can track Incyte Corporation financials in yearly and quarterly reports right on TradingView.
Like other stocks, INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Incyte Corporation stock right from TradingView charts — choose your broker and connect to your account.
INCY reached its all-time high on Mar 15, 2017 with the price of 153.15 USD, and its all-time low was 1.66 USD and was reached on Sep 22, 1994.
See other stocks reaching their highest and lowest prices.
As of Apr 13, 2024, the company has ‪2.52 K‬ employees. See our rating of the largest employees — is Incyte Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Incyte Corporation EBITDA is ‪734.43 M‬ USD, and current EBITDA margin is 19.87%. See more stats in Incyte Corporation financial statements.